Pages

January 8, 2015

Lexaria Commissions Cannabinoid Education Series

Yahoo! FinanceLexaria,
Corp. (LXRP) (CSE:LXX) (the "Company") has engaged Michelle Reillo,
PhD, to write a series of manuals providing guidance to both consumers
of CBD and practitioners who advise patients in their use of CBD. This
wide ranging series will offer guidance and instruction as to how to
maximize performance, health, and wellness through the proper and
regimented consumption of Cannabidiol.

Lexaria recognizes there is an
enormous information vacuum with respect to cannabidiol (CBD), its
usage, and the health benefits it provides. For those who wish to
immediately learn more, we refer you to the beta version of our www.vipova.com
website where you can find the US Government's patent on cannabidiol,
Patent # 6630507, which provides a broad overview of the health benefits
associated with CBD.